United Therapeutics Corp (NASDAQ:UTHR)

172.44
Delayed Data
As of Mar 31
 -4.37 / -2.47%
Today’s Change
84.63
Today|||52-Week Range
181.61
+33.16%
Year-to-Date

Today’s Trading

Previous close176.81
Today’s open175.58
Day’s range171.50 - 177.85
Volume1,060,507
Average volume (3 months)619,765
Market cap$8.3B
Dividend yield--
Data as of 4:00pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+91.46%
Earnings growth (this year)+54.78%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+15.36%
P/E ratio27.5
Price/Sales4.84
Price/Book6.70

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-3.65-1.52%
IDXXIDEXX Laboratories I...-1.63-1.04%
ALKSAlkermes Plc-1.55-2.48%
RDYDr.Reddy's Laborator...+1.43+2.57%
Data as of 4:02pm ET, 03/31/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.29
Annual revenue (last year)$1.3B
Annual profit (last year)$340.1M
Net profit margin26.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account